Literature DB >> 22495331

Ocular neovascularization associated with central and hemicentral retinal vein occlusion.

Sohan Singh Hayreh1, M Bridget Zimmerman.   

Abstract

PURPOSE: To investigate the incidence of ocular neovascularization (NV) in central and hemicentral retinal vein occlusion.
METHODS: The study comprised consecutive 912 (673 nonischemic and 239 ischemic) central retinal vein occlusion and 190 (147 nonischemic, 43 ischemic) hemicentral retinal vein occlusion eyes. Ophthalmic evaluation at initial and follow-up visits included recording visual acuity, visual fields, and detailed anterior segment and fundus examinations and fluorescein fundus angiography.
RESULTS: In ischemic central retinal vein occlusion, within 6 months from time of onset, the cumulative probability of development of iris NV was 49%, angle NV 37%, NV glaucoma 29%, retinal NV 9%, and disk NV 6%. More severe peripheral retinal hemorrhages were significantly associated with iris NV (P = 0.005), angle NV (P = 0.0004), and NV glaucoma (P = 0.012). Eyes that developed disk NV had more cotton wool spots (P = 0.058) than those without. In ischemic hemicentral retinal vein occlusion, within 12 months of onset, the cumulative probability of development of retinal NV was 29%, disk NV 12%, and iris NV 12%; within 6 months of onset, angle NV was found in 10% and NV glaucoma in 5%. Anterior chamber flare was associated with anterior segment NV and may precede the development of NV. Patients who developed NV were significantly younger, and there was a greater prevalence of NV glaucoma in patients with primary open angle glaucoma.
CONCLUSION: In ischemic central retinal vein occlusion, anterior segment NV is much more common than posterior segment NV, and the cumulative chance of developing anterior segment NV is maximum during the first 6 months. In ischemic hemicentral retinal vein occlusion, posterior segment NV is much more common than anterior segment NV.

Entities:  

Mesh:

Year:  2012        PMID: 22495331     DOI: 10.1097/IAE.0b013e318246912c

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  22 in total

Review 1.  Ocular vascular occlusive disorders: natural history of visual outcome.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2014-04-21       Impact factor: 21.198

2.  Comment on 'The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary'.

Authors:  S S Hayreh
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

3.  Venous oxygen saturation is reduced and variable in central retinal vein occlusion.

Authors:  Thorunn Scheving Eliasdottir; David Bragason; Sveinn Hakon Hardarson; Gudrun Kristjansdottir; Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-18       Impact factor: 3.117

4.  Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion.

Authors:  Andrew J Rong; Swarup S Swaminathan; Elizabeth A Vanner; Richard K Parrish
Journal:  Am J Ophthalmol       Date:  2019-03-09       Impact factor: 5.258

5.  Fundus changes in central retinal vein occlusion.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Retina       Date:  2015-01       Impact factor: 4.256

6.  Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study).

Authors:  Matus Rehak; Eric Tilgner; Annegret Franke; Franziska G Rauscher; Oana Brosteanu; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-12-18       Impact factor: 3.117

7.  The nexus between VEGF and NFκB orchestrates a hypoxia-independent neovasculogenesis.

Authors:  Michael DeNiro; Falah H Al-Mohanna; Osama Alsmadi; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

8.  The effect of antivascular endothelial growth factor therapy on the development of neovascular glaucoma after central retinal vein occlusion: a retrospective analysis.

Authors:  Christina L Ryu; Adrian Elfersy; Uday Desai; Thomas Hessburg; Paul Edwards; Hua Gao
Journal:  J Ophthalmol       Date:  2014-04-01       Impact factor: 1.909

9.  MicroRNA-410 reduces the expression of vascular endothelial growth factor and inhibits oxygen-induced retinal neovascularization.

Authors:  Na Chen; Jiaqi Wang; Yijun Hu; Bei Cui; Wenjie Li; Guixia Xu; Lin Liu; Shanrong Liu
Journal:  PLoS One       Date:  2014-04-28       Impact factor: 3.240

10.  Nuclear factor kappa-B signaling is integral to ocular neovascularization in ischemia-independent microenvironment.

Authors:  Michael DeNiro; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.